Status: current, Primitive. Date: 31-Aug 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4076601000168115 | Atelvia EC Once-a-Week (risedronate sodium 35 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4076611000168117 | Atelvia EC Once-a-Week 35 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Atelvia EC Once-a-Week 35 mg tablet | Is a | Atelvia EC Once-a-Week | true | Inferred relationship | Some | ||
| Atelvia EC Once-a-Week 35 mg tablet | Is a | risedronate sodium 35 mg tablet | true | Inferred relationship | Some | ||
| Atelvia EC Once-a-Week 35 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Atelvia EC Once-a-Week 35 mg tablet | has manufactured dose form | film-coated tablet | false | Inferred relationship | Some | ||
| Atelvia EC Once-a-Week 35 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 1085703530 | |
| Atelvia EC Once-a-Week 35 mg tablet | has intended active ingredient | risedronate | true | Inferred relationship | Some | 1085703529 | |
| Atelvia EC Once-a-Week 35 mg tablet | has Australian BoSS | risedronate sodium | true | Inferred relationship | Some | 1085703529 | |
| Atelvia EC Once-a-Week 35 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some |
Reference Sets
Trade product unit of use reference set
FHIR